Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

1.220 -0.040 (-3.17%)
Streaming Delayed Price Updated: 9:30 AM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning! 
Via InvestorPlace
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Gold Gains 1%; Best Buy Posts Upbeat Earnings
 
Via Benzinga
Nasdaq Down Over 100 Points; US Crude Oil Inventories Decline
 
Via Benzinga
Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
Dow Tumbles Over 300 Points; Dollar General Earnings Top Views
 
Via Benzinga
Topics Stocks
Why Is UiPath (PATH) Stock Down 30% Today?
UiPath stock is falling on Thursday after investors in PATH learned of a CEO change and a weak outlook in its latest earnings report. 
Via InvestorPlace
Why Is NovaBay Pharmaceuticals (NBY) Stock Down 39% Today?
NovaBay Pharmaceuticals stock is down on Thursday after the company announced a reverse split for shares of NBY happening today. 
Via InvestorPlace
Why Pure Storage Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning! 
Via InvestorPlace
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
NovaBay Pharmaceuticals Stock Is Up 50%: What's Going On?
NovaBay Pharmaceuticals shares are trading higher by 50% Monday afternoon. The marked move higher comes despite a lack of company-specific news for the session. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The final day of trading this week is here and we have the biggest pre-market stock movers worth watching on Friday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.